Best of Hematology and Breast Cancer 2025, Seattle
The Best of Hematology and Breast Cancer 2025 conference in Seattle is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications.
Focusing on a multidisciplinary approach, the event aims to integrate new advancements into patient-centered care. Designed for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other professionals, attendees will engage with colleagues and experts to critically evaluate data and improve patient outcomes.
The Best of Hematology and Breast Cancer 2025, Seattle, is an educational activity planned by the Binaytara Foundation. Neither Binaytara Foundation nor this activity are affiliated with the American Society of Hematology (ASH) or the San Antonio Breast Cancer Symposium (SABCS).
Target Audience
- Hematologists, Oncologists
- Surgeons
- Radiation Oncologists
- Physician Assistants/Nurse Practitioners
- Pharmacists
- Nurses
Organizing Committee
Conference Director:
Binay Shah, MD, MHA - Binaytara Foundation
Conference Co-Chairs:
Fengting Yan, MD, FACP - Swedish
Andrew J. Cowan, MD - Fred Hutch Cancer Center
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Summarize the latest updates from ASH24 and SABCS24, focusing on their implications for clinical practice in managing hematologic disorders and breast cancer.
- Assess new therapeutic options for benign and malignant hematologic disorders and breast cancer, including appropriate indications and contraindications presented at ASH24 and SABCS24.
- Examine the study design, primary endpoints, and impact of recent and ongoing clinical trials from ASH24 and SABCS24 that have influenced current standards of care.
- Incorporate evolving diagnostic, prognostic, and therapeutic strategies from ASH24 and SABCS24 into patient management for hematologic disorders and breast cancer.
- Apply emerging data from clinical trials and updated expert guidelines from ASH24 and SABCS24 to individualize patient management strategies.
Hotel Room Reservation
A limited number of guestrooms are reserved at the Grand Hyatt Seattle for the participants of this meeting at a discounted rate of $179 per night. The room rate does not include any additional fees or applicable taxes.
Please use the link below to reserve your room for the discounted rate. The rate is good through Tuesday December 3, 2024
Booking link coming soon...
Parking
The hotel offers overnight valet parking for $68.
GLOBAL ONCOLOGY PROJECT
Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/
DAY 1 – Friday, January 3, 2025
All times are listed in Pacific Time (PT)
02:00 PM – 03:00 PM Registration
03:00 PM – 04:00 PM Session 1: Case-Based Discussion: Classical Hematology
Session Chair: David Aboulafia, MD
03:00 PM – 03:15 PM HUS/TTP - Livia Hegerova, MD
03:15 PM – 03:30 PM PNH - Matthew Schwede, MD
03:30 PM – 03:45 PM Anemia -
03:45 PM – 04:00 PM Bone Marrow Failure -
04:00 PM – 05:00 PM Session 2: Case-Based Discussion: Bleeding and Clotting Disorder
Session Chair:
04:00 PM – 04:30 PM Bleeding Disorders - Jill Johnsen, MD
04:30 PM – 05:00 PM Clotting Disorders -
05:00 PM – 06:00 PM Vendor Reception
DAY 2 – Saturday, January 4, 2025
07:00 AM – 08:00 AM Registration, Exhibits & Breakfast
08:00 AM – 08:05 AM Welcome
08:05 AM – 08:30 AM Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
08:30 AM – 09:30 AM Session 3: Acute Leukemia
Session Chair: Roland Walter, MD, PhD, MS
08:30 AM – 09:00 AM Acute Myeloid Leukemia/MDS - Roland Walter, MD, PhD, MS
09:00 AM – 09:30 AM Acute Lymphoblastic Leukemia - Ryan Cassaday, MD
09:30 AM – 10:45 AM Session 4: Lymphoma
Session Chair: Mazyar Shadman, MD, MPH
09:30 AM – 09:55 AM B-Cell Lymphoma - Mengyang Di, MD, PhD
09:55 AM – 10:20 AM CLL - Bita Fakhri, MD, MPH
10:20 AM – 10:45 AM T-Cell Lymphoma - Christina Poh, MD
10:45 AM – 11:00 AM Break & Exhibits
11:00 AM – 12:00 PM Session 5: Multiple Myeloma
Session Chair: Mary Kwok, MD
11:00 AM – 11:30 AM Frontline Therapy of Multiple Myeloma - Rahul Banerjee, MD, FACP
11:30 AM – 12:00 PM Relapsed/Recurrent Multiple Myeloma - Danai Dima, MD
12:00 PM – 01:00 PM Lunch & Exhibits
01:00 PM – 02:00 PM Session 6: Hematologic Malignancies
Session Chairs: Jerald Radich, MD
01:00 PM – 01:30 PM Myeloproliferative Neoplasms - Rachel B. Salit, MD
01:30 PM – 02:00 PM Cellular Therapy - Alexandre V. Hirayama MD
02:00 PM – 02:15 PM Break & Exhibits
02:15 PM – 03:45 PM Session 7: Updates in Management of Breast Cancer
Session Chair:
02:15 PM – 02:45 PM HER2 Positive Breast Cancer - William R. Gwin III, MD
02:45 PM – 03:15 PM Triple Negative and HER2 Low Breast Cancer -
03:15 PM – 03:45 PM HR Positive Breast Cancer - Hannah Linden, MD
03:45 PM – 04:15 PM Session 8: Tumor Board-Style Case-Based Discussion: Breast Cancer
Session Chair: Fengting Yan, MD, FACP
03:45 PM – 03:55 PM HER2 Low and Ultralow Disease -
03:55 PM – 04:05 PM High Risk Early Stage Breast Cancer -
04:05 PM – 04:15 PM Panel Discussion -
04:15 PM – 05:00 PM Session 9 - HRT Debate: Is it Safe?
Session Chair:
04:15 PM – 04:20 PM HRT Safety & Efficacy Overview -
04:20 PM – 04:30 PM Yes -
04:30 PM – 04:40 PM No -
04:40 PM – 05:00 PM Panel Discussion - Michaela L. Tsai, MD
05:00 PM Adjourn
Hotel Room Reservation
A limited number of guestrooms are reserved at the Grand Hyatt Seattle for the participants of this meeting at a discounted rate of $179 per night. The room rate does not include any additional fees or applicable taxes.
CUTOFF - Tuesday December 3, 2024
Please use the link below to reserve your room for the discounted rate. The rate is good through Tuesday December 3, 2024
Booking link coming soon...
Parking
The hotel offers overnight valet parking for $68.
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Andrew Cowan, MD
Fengting Yan, MD
David Aboulafia, MD
Jerald Radich, MD
Roland Walter, MD PhD MS
Rahul Banerjee, MD, FACP
Ryan Cassaday, MD
Danai Dima, MD
Bita Fakhri, Bita Fakhri, MD, MPH
Alexandre Hirayama, MD
Mary Kwok
Hannah Linden, MD FACP
Christina Poh, MD
Matthew Schwede, MD, MS
Michaela Tsai, MD
Available Credit
- 8.50 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 8.50 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 8.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 8.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 8.50 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 8.50 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.